ArticleHuman cell2022

Ephrin (Eph) receptor and downstream signaling pathways: a promising potential targeted therapy for COVID‑19 and associated cancers and diseases.

Hamidreza Zalpoor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.